Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Terminated 2Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 5OTHER 4NIH 1NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 2Breast 1

Conditions

Endometrial Neoplasms 2Endometrial Hyperplasia 2Breast Neoplasms 1Body Weight Changes 1Anorexia 1

Interventions

Cyclophosphamide 548pembrolizumab 385Radiotherapy 363Bevacizumab 360Carboplatin 351Rituximab 315Cisplatin 300Gemcitabine 297Paclitaxel 288Dexamethasone 272Docetaxel 271fludarabine phosphate 241Doxorubicin 231Nivolumab 220Etoposide 209Cytarabine 203Lenalidomide 201fludarabine 191Oxaliplatin 191Fluorouracil 190Melphalan 189Filgrastim 188Capecitabine 175Calcium Dobesilate 172Radiosurgery 167Erlotinib Hydrochloride 167Methotrexate 163Bortezomib 162Granulocyte Colony-Stimulating Factor 154Whole-Body Irradiation 144

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Has results × Megestrol Acetate × Clear all
NCT03671811 2026-06-03

Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy

City of Hope Medical Center

Phase 2 Active not recruiting
44 enrolled 12 charts
Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

NCT02269670 2022-04-05

Phase II Study of Everolimus Beyond Progression

Emory University

Phase 2 Terminated
3 enrolled 4 charts
Breast

Breast Neoplasms

NCT00483327 2018-04-04

Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate

NYU Langone Health

Phase 2 Completed
31 enrolled 9 charts
Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

NCT01200602 2015-11-25

Megestrol Acetate in Treating Weight Loss or Anorexia in Young Patients With Malignancies Who Are Undergoing Radiation Therapy and/or Chemotherapy

Mayo Clinic

Phase 2 Terminated
1 enrolled

Anorexia, Body Weight Changes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡